Dishman Pharmaceuticals & Chemicals Ltd.[Merged] - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Jun' 17	Mar' 17	Dec' 16	Sep' 16	Jun' 16

Sales

92.64

128.30

101.49

120.48

91.05

Operating profit

24.81

35.45

32.11

43.09

33.13

Interest

7.35

3.24

7.46

9.97

16.30

Gross profit

21.01

69.76

30.19

58.59

21.77

EPS (Rs)

-0.53

1.25

1.00

2.34

0.52

Other income

3.55

37.55

5.54

25.47

4.94

Stock adjustment

-10.47

7.40

-9.26

-0.45

-8.16

Raw material

34.20

36.72

32.54

37.03

31.64

Power and fuel

-

-

-

-

-

Employee expenses

12.83

15.33

18.37

19.87

15.41

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

31.27

33.40

27.73

20.94

19.03

Provisions made

-

-

-

-

-

Depreciation

34.18

34.08

11.18

11.48

11.20

Taxation

-4.69

15.50

2.90

9.36

2.15

Net profit / loss

-8.48

20.18

16.11

37.75

8.42

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

32.28

32.28

32.28

32.28

32.28

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

26.78

27.63

31.64

35.77

36.39

GPM (%)

21.84

42.06

28.21

40.14

22.68

NPM (%)

-8.82

12.17

15.05

25.87

8.77